RiboTag-based RNA-Seq uncovers oligodendroglial lineage-specific inflammation in autoimmune encephalomyelitis
Yuhang Wang1, Sudeep Ghimire1, Ashutosh Mangalam1
1Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
Biorxiv : the Preprint Server for Biology
|January 7, 2025
Summary
Oligodendroglial lineage cells (OLCs) actively contribute to neuroinflammation in Multiple Sclerosis models. Targeting OLC inflammatory pathways, particularly interferon-gamma responses, may offer new therapeutic strategies for MS.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Oligodendroglial lineage cells (OLCs) are vital for neuronal support and myelination.
- Recent research highlights OLCs' active participation in neuroinflammatory processes, especially in Multiple Sclerosis (MS).
Purpose of the Study:
- To investigate the inflammatory gene expression profile (translatome) of OLCs during the early stages of experimental autoimmune encephalomyelitis (EAE), a model for MS.
- To elucidate the specific roles of OLCs in the neuroinflammatory cascade.
Main Methods:
- Utilized RiboTag-based RNA sequencing in Olig2-Cre RiboTag mice to profile OLCs during EAE.
- Performed enrichment analysis to identify key biological pathways affected in EAE OLCs.
- Conducted functional studies using interferon-gamma (IFN-γ) and interferon-beta (IFN-β) signaling modulators.
Main Results:
- Identified significant upregulation of immune-related genes (cytokine signaling, interferon responses, antigen presentation) and downregulation of neuronal development/myelination genes in EAE OLCs.
- Confirmed OLC expression of cytokines, chemokines, and their receptors, indicating active participation in inflammatory signaling.
- Demonstrated that IFN-γ signaling in OLCs exacerbates EAE pathology by increasing antigen presentation and chemokine production, while IFN-β had minimal effect.
Conclusions:
- OLCs play a significant inflammatory role in EAE, extending beyond their traditional supportive functions.
- IFN-γ signaling in OLCs is a key driver of pathology in this MS model.
- Targeting OLC-mediated neuroinflammation presents a potential therapeutic avenue for MS and related autoimmune neurological disorders.


